Q1-2023 Pharmacy & Infusion Services Update
In Q1-23, healthcare providers continued expanding upon their home infusion service lines as site-of-care strategies grow in importance. The COVID-19 pandemic increased demand for home-based care, boosting growth in the home infusion therapy sector. Home infusion therapy offers various benefits including convenience, cost-effectiveness, better outcomes, and higher safety standards.
Provident anticipates that deal flow will remain high as healthcare systems continue to invest in home infusion service lines.
Sellers seeking M&A opportunities to either exit their ownership positions or find a strategic partner to drive growth are positioned to benefit from this continued investor interest and a growing community of well-financed, growth-oriented buyers.
To print and download the full Pharmacy & Infusion Update report, please click below…
